Clinical Trial Update: Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates metformin with neoadjuvant temozolomide and hypo-accelerated radiotherapy followed by adjuvant temozolomide in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• metformin (metformin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING